Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Cancer Survivors Program [NA]
A cancer survivors program trial sponsored by Masaryk Memorial Cancer Institute is currently recruiting and involves prostate and breast can…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Prevention of CIPN Using Compressive Therapy [NA]
This clinical trial is studying whether compressive therapy can prevent chemotherapy-induced peripheral neuropathy in adjuvant breast cancer…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy [Phase 3]
Phase 3 trial evaluating ribociclib as adjuvant therapy in hormone receptor-positive, HER2-negative early breast cancer with residual diseas…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging [Phase 2]
Phase 2 clinical trial evaluating optimized dynamic neoadjuvant therapy for HER2-positive breast cancer guided by HER2-PET/CT imaging; curre…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Surgical Glove Compression to Prevent Paclitaxel Neuropathy [NA]
Necmettin Erbakan University is testing whether surgical glove compression can prevent paclitaxel-induced peripheral neuropathy in breast ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Proton vs Photon IMRT Toxicity in Breast Cancer
This clinical trial update compares proton versus photon IMRT toxicity in breast cancer, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4257496 in Participants With Cancer (OMNIRAY) [Phase 1]
Phase 1 clinical trial update for LY4257496 in cancer patients; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer [Phase 3]
A Phase 3 trial of Dato-DXd (datopotamab deruxtecan) is evaluating inoperable or metastatic hormone receptor-positive, HER2 IHC 0 breast can…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
A Wake Forest University Health Sciences trial is currently recruiting to study self-reported pain in women undergoing treatment for non-met…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer [Phase 2]
A Phase 2 trial of imlunestrant (LY3484356) in premenopausal women with ER-positive, HER2-negative early breast cancer is not yet recruiting…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of thermal ablation and spine stereotactic radiosurgery for spine metasta…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Quantitative MRI Assessment of Breast Cancer Therapy Response
An ongoing clinical trial is evaluating quantitative MRI to assess breast cancer therapy response and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions [NA]
This clinical trial update indicates that ARTIDIS nanomechanical measurements for early breast lesions are currently recruiting for investig…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. [NA]
A clinical trial assessing quality of life after facial hyaluronic acid injections in patients treated for breast cancer; the study is not y…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial sponsored by Henan Cancer Hospital evaluating Utidelone in combination with Bevacizumab for HER2-negative advanced …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
A clinical trial compares synthetic mammography to full-field digital mammography for image interpretation and performance metrics in breast…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME) [NA]
This clinical trial update describes a study evaluating capillary microsampling for therapeutic drug monitoring of CDK4/6 inhibitors in brea…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy [NA]
An ongoing clinical trial evaluating whether a cold salt water foot bath can affect the development of chemotherapy-induced peripheral neuro…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating whether functional imaging can predict response to abemaciclib in advanced hormone receptor-positive, HER2-negati…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating Palazestrant in combination with ribociclib as first-line therapy for ER+/HER2- advanced/metastatic breast cancer; …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Luminal Breast Cancer Cryoablation [NA]
The clinical trial update indicates a luminal breast cancer cryoablation study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Impact of Regional Anesthesia on Chronic Post-operative Pain
A clinical trial assessing the effect of regional anesthesia on chronic post-operative pain in breast cancer patients is currently enrolling…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating adding stereotactic body radiation therapy to standard drug therapy for breast cancer, including olig…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer [NA]
A clinical trial at MD Anderson is evaluating a decision-making tool to assist patients with newly diagnosed breast cancer in deciding about…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of capecitabine given on a 7/7 schedule in combination with neratinib for metastatic …